1. A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment. Issue 2 (26th October 2020) Authors: Tatosian, Daniel A.; Yee, Ka Lai; Zhang, Zufei; Mostoller, Kate; Paul, Erina; Sutradhar, Santosh; Larson, Patrick; Chhibber, Aparna; Wen, Jianzhong; Wang, Ya‐Juan; Lassman, Michael; Latham, Andrew H.; Pang, Jianmei; Crumley, Tami; Gillespie, Anne; Marricco, Nadia Cardillo; Marenco, Ted; Murphy, M... Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 2(2021) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment. Issue 2 (26th October 2020) Authors: Tatosian, Daniel A.; Yee, Ka Lai; Zhang, Zufei; Mostoller, Kate; Paul, Erina; Sutradhar, Santosh; Larson, Patrick; Chhibber, Aparna; Wen, Jianzhong; Wang, Ya‐Juan; Lassman, Michael; Latham, Andrew H.; Pang, Jianmei; Crumley, Tami; Gillespie, Anne; Marricco, Nadia Cardillo; Marenco, Ted; Murphy, M... Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 2(2021) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Application of a Rat Liver Drug Bioactivation Transcriptional Response Assay Early in Drug Development That Informs Chemically Reactive Metabolite Formation and Potential for Drug-induced Liver Injury. (19th June 2020) Authors: Monroe, James J; Tanis, Keith Q; Podtelezhnikov, Alexei A; Nguyen, Truyen; Machotka, Sam V; Lynch, Donna; Evers, Raymond; Palamanda, Jairam; Miller, Randy R; Pippert, Todd; Cabalu, Tamara D; Johnson, Timothy E; Aslamkhan, Amy G; Kang, Wen; Tamburino, Alex M; Mitra, Kaushik; Agrawal, Nancy G B; Si... Journal: Toxicological sciences Issue: Volume 177:Number 1(2020) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG. (April 2016) Authors: Brian, William; Tremaine, Larry M; Arefayene, Million; de Kanter, Ruben; Evers, Raymond; Guo, Yingying; Kalabus, James; Lin, Wen; Loi, Cho-Ming; Xiao, Guangqing Journal: Pharmacogenomics Issue: Volume 17:Number 6(2016) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Assessment of Pharmacokinetic Interaction Between Gefapixant (MK‐7264), a P2X3 Receptor Antagonist, and the OATP1B1 Drug Transporter Substrate Pitavastatin. Issue 3 (24th November 2021) Authors: McCrea, Jacqueline B.; Hussain, Azher; Ma, Bennett; Garrett, Graigory C.; Evers, Raymond; Laabs, John E.; Stoch, S. Aubrey; Iwamoto, Marian Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 3(2022) Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Assessment of the Effect of Pyrimethamine, a Potent Inhibitor of Multidrug and Toxin Extrusion Protein 1/2K, on the Pharmacokinetics of Gefapixant (MK‐7264), a P2X3 Receptor Antagonist. Issue 1 (19th June 2021) Authors: Nussbaum, Jesse C.; Hussain, Azher; Ma, Bennett; Min, K. Chris; Evers, Raymond; Li, Yun; Garrett, Graigory; Stoch, S. Aubrey; Iwamoto, Marian Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 1(2022) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition. (1st September 2022) Authors: Yamazaki, Shinji; Evers, Raymond; De Zwart, Loeckie Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 10(2022) Page Start: 1394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium. Issue 5 (12th July 2018) Authors: Evers, Raymond; Piquette‐Miller, Micheline; Polli, Joseph W.; Russel, Frans G.M.; Sprowl, Jason A.; Tohyama, Kimio; Ware, Joseph A.; de Wildt, Saskia N.; Xie, Wen; Brouwer, Kim L.R. Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 5(2018) Page Start: 900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood–Brain Barrier Measured by Quantitative Targeted Proteomics. Issue 1 (18th March 2019) Authors: Billington, Sarah; Salphati, Laurent; Hop, Cornelis E. C. A.; Chu, Xiaoyan; Evers, Raymond; Burdette, Doug; Rowbottom, Christopher; Lai, Yurong; Xiao, Guangqing; Humphreys, W. Griffith; Nguyen, Tot Bui; Prasad, Bhagwat; Unadkat, Jashvant D. Journal: Clinical pharmacology & therapeutics Issue: Volume 106:Issue 1(2019) Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P234 - Use of a bile salt export pump knockdown rat susceptibility model to interrogate mechanism of drug induced liver toxicity. (2020) Authors: Li, Yutai; Evers, Raymond; Hafey, Michael; Cheon, Kyeongmi; Duong, Hong; LaFranco-Scheuch, Lisa; Tamburino, Alex; Pearson, Kara; Lebron, Jose; Glaab, Warren; Sistare, Frank Journal: Drug metabolism and pharmacokinetics Issue: Volume 35(2020)Supplement 1 Page Start: S93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗